Literature DB >> 29900402

Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Fabio A Zucca1, Renzo Vanna1,2, Francesca A Cupaioli1, Chiara Bellei1, Antonella De Palma1, Dario Di Silvestre1, Pierluigi Mauri1, Sara Grassi3, Alessandro Prinetti3, Luigi Casella4, David Sulzer5,6,7, Luigi Zecca1,5.   

Abstract

During aging, neuronal organelles filled with neuromelanin (a dark-brown pigment) and lipid bodies accumulate in the brain, particularly in the substantia nigra, a region targeted in Parkinson's disease. We have investigated protein and lipid systems involved in the formation of these organelles and in the synthesis of the neuromelanin of human substantia nigra. Membrane and matrix proteins characteristic of lysosomes were found in neuromelanin-containing organelles at a lower number than in typical lysosomes, indicating a reduced enzymatic activity and likely impaired capacity for lysosomal and autophagosomal fusion. The presence of proteins involved in lipid transport may explain the accumulation of lipid bodies in the organelle and the lipid component in neuromelanin structure. The major lipids observed in lipid bodies of the organelle are dolichols with lower amounts of other lipids. Proteins of aggregation and degradation pathways were present, suggesting a role for accumulation by this organelle when the ubiquitin-proteasome system is inadequate. The presence of proteins associated with aging and storage diseases may reflect impaired autophagic degradation or impaired function of lysosomal enzymes. The identification of typical autophagy proteins and double membranes demonstrates the organelle's autophagic nature and indicates that it has engulfed neuromelanin precursors from the cytosol. Based on these data, it appears that the neuromelanin-containing organelle has a very slow turnover during the life of a neuron and represents an intracellular compartment of final destination for numerous molecules not degraded by other systems.

Entities:  

Year:  2018        PMID: 29900402      PMCID: PMC5988730          DOI: 10.1038/s41531-018-0050-8

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  136 in total

1.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.

Authors:  Bing Li; Ana P Castano; Thomas E Hudson; Brian T Nowlin; Shuei-Liong Lin; Joseph V Bonventre; Kenneth D Swanson; Jeremy S Duffield
Journal:  FASEB J       Date:  2010-08-13       Impact factor: 5.191

Review 2.  The proteome of lysosomes.

Authors:  Bernd A Schröder; Christian Wrocklage; Andrej Hasilik; Paul Saftig
Journal:  Proteomics       Date:  2010-10-19       Impact factor: 3.984

3.  Identification of sites of mannose 6-phosphorylation on lysosomal proteins.

Authors:  David E Sleat; Haiyan Zheng; Meiqian Qian; Peter Lobel
Journal:  Mol Cell Proteomics       Date:  2006-01-05       Impact factor: 5.911

4.  Role of galactosylceramide and sulfatide in oligodendrocytes and CNS myelin: formation of a glycosynapse.

Authors:  Joan M Boggs
Journal:  Adv Neurobiol       Date:  2014

5.  Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Authors:  K L Double; L Zecca; P Costi; M Mauer; C Griesinger; S Ito; D Ben-Shachar; G Bringmann; R G Fariello; P Riederer; M Gerlach
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

6.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

7.  Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).

Authors:  Cristian Follmer; Eduardo Coelho-Cerqueira; Danilo Y Yatabe-Franco; Gabriel D T Araujo; Anderson S Pinheiro; Gilberto B Domont; David Eliezer
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

8.  Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain.

Authors:  Weslyn C Ward; Ziqiang Guan; Fabio A Zucca; Ruggero G Fariello; Reza Kordestani; Luigi Zecca; Christian R H Raetz; John D Simon
Journal:  J Lipid Res       Date:  2007-04-19       Impact factor: 5.922

Review 9.  Proteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome.

Authors:  Sarah Plum; Simone Steinbach; Laura Abel; Katrin Marcus; Stefan Helling; Caroline May
Journal:  Proteomics Clin Appl       Date:  2014-11-10       Impact factor: 3.494

10.  MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.

Authors:  Carolina Cebrián; Fabio A Zucca; Pierluigi Mauri; Julius A Steinbeck; Lorenz Studer; Clemens R Scherzer; Ellen Kanter; Sadna Budhu; Jonathan Mandelbaum; Jean P Vonsattel; Luigi Zecca; John D Loike; David Sulzer
Journal:  Nat Commun       Date:  2014-04-16       Impact factor: 14.919

View more
  35 in total

Review 1.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

2.  The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.

Authors:  Xiangming Wang; Yuehui Zhang; Chen Zhu; Guangzong Li; Jie Kang; Fang Chen; Ling Yang
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

Review 3.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

4.  Standardized Data Acquisition for Neuromelanin-sensitive Magnetic Resonance Imaging of the Substantia Nigra.

Authors:  Guillermo Horga; Kenneth Wengler; Garrett Salzman; Jocelyn Kim
Journal:  J Vis Exp       Date:  2021-09-08       Impact factor: 1.424

Review 5.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

6.  Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose (Alces alces) Presenting with Signs of Blindness and Circling.

Authors:  Madhu Ravi; Atilano Lacson; Margo Pybus; Mark C Ball
Journal:  Animals (Basel)       Date:  2022-06-25       Impact factor: 3.231

Review 7.  MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.

Authors:  Sephira G Ryman; Kathleen L Poston
Journal:  Parkinsonism Relat Disord       Date:  2019-10-10       Impact factor: 4.891

8.  Protective Effects of Crude Plant Extracts against Aminochrome-induced toxicity in Human Astrocytoma Cells: Implications for Parkinson's Disease.

Authors:  Viviane L Ndam Ngoungoure; Patricia Muñoz; Yousef Tizabi; Raul Valdes; Paul Fewou Moundipa; Juan Segura-Aguilar
Journal:  Clin Pharmacol Transl Med       Date:  2019-04-08

9.  Cross-Scanner Harmonization of Neuromelanin-Sensitive MRI for Multisite Studies.

Authors:  Kenneth Wengler; Clifford Cassidy; Marieke van der Pluijm; Jodi J Weinstein; Anissa Abi-Dargham; Elsmarieke van de Giessen; Guillermo Horga
Journal:  J Magn Reson Imaging       Date:  2021-05-06       Impact factor: 5.119

Review 10.  Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models.

Authors:  Andrea Capucciati; Fabio A Zucca; Enrico Monzani; Luigi Zecca; Luigi Casella; Tim Hofer
Journal:  Antioxidants (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.